Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

Anna Collado; Maria Paola Boaro; Sigrid Van Der Veen; Amira Idrizovic; Bart J. Biemond; David Beneitez Pastor; Ana Ortuño; Elena Cela; Anna Ruiz-Llobet; Pablo Bartolucci; Marianne De Montalembert; Gastone Castellani; Riccardo Biondi; Renzo Manara; Tiziana Sanavia; Piero Fariselli; Petros Kountouris; Marina Kleanthous; Federico Alvarez; Santiago Zazo; Raffaella Colombatti; Eduard J. Van Beers; María Del Mar Mañú-Pereira

doi:10.1097/HS9.0000000000000844

Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

Anna Collado
, Maria Paola Boaro
, Sigrid Van Der Veen
, Amira Idrizovic
, Bart J. Biemond
, David Beneitez Pastor
, Ana Ortuño
, Elena Cela
, Anna Ruiz-Llobet
, Pablo Bartolucci
, Marianne De Montalembert
, Gastone Castellani
, Riccardo Biondi
, Renzo Manara
, Tiziana Sanavia
, Piero Fariselli
, Petros Kountouris
, Marina Kleanthous
, Federico Alvarez
, Santiago Zazo

Raffaella Colombatti, Eduard J. Van Beers, María Del Mar Mañú-Pereira^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

7 Downloads (Pure)

Original language	English
Article number	e844
Number of pages	3
Journal	HemaSphere
Volume	7
Issue number	3
DOIs	https://doi.org/10.1097/HS9.0000000000000844
Publication status	Published - Mar 2023

Access to Document

10.1097/HS9.0000000000000844Licence: CC BY

challenges_and_opportunities_of_precision_medicine.7Final published version, 329 KBLicence: CC BY

Cite this

Collado, A., Boaro, M. P., Van Der Veen, S., Idrizovic, A., Biemond, B. J., Beneitez Pastor, D., Ortuño, A., Cela, E., Ruiz-Llobet, A., Bartolucci, P., De Montalembert, M., Castellani, G., Biondi, R., Manara, R., Sanavia, T., Fariselli, P., Kountouris, P., Kleanthous, M., Alvarez, F., ... Mañú-Pereira, M. D. M. (2023). Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet. HemaSphere, 7(3), Article e844. https://doi.org/10.1097/HS9.0000000000000844

@article{1d043ae46d9f4163ad7ad4365ec90ac2,

title = "Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet",

author = "Anna Collado and Boaro, \{Maria Paola\} and \{Van Der Veen\}, Sigrid and Amira Idrizovic and Biemond, \{Bart J.\} and \{Beneitez Pastor\}, David and Ana Ortu{\~n}o and Elena Cela and Anna Ruiz-Llobet and Pablo Bartolucci and \{De Montalembert\}, Marianne and Gastone Castellani and Riccardo Biondi and Renzo Manara and Tiziana Sanavia and Piero Fariselli and Petros Kountouris and Marina Kleanthous and Federico Alvarez and Santiago Zazo and Raffaella Colombatti and \{Van Beers\}, \{Eduard J.\} and Ma{\~n}{\'u}-Pereira, \{Mar{\'i}a Del Mar\}",

note = "Funding Information: GA 101017549 – GENOMED4ALL - H2020-SC1-FA-DTS-2020-1. {\textquoteleft}Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases{\textquoteright}. Instituto de Salud Carlos III through the project {\textquoteleft}PI20/01454: ENABLING PERSONALIZED MEDICINE OF SICKLE CELL DISEASE PATIENTS BASED ON INTEGRATIVE DIAGNOSIS OF NEW GENERATION METHODOLOGIES{\textquoteright} (Co-funded by European Regional Development Fund/European Social Fund; {\textquoteleft}A way to make Europe{\textquoteright}/{\textquoteright}Investing in your future”). GA 101085717 - ERN-EuroBloodNet – EU4H-2022-ERN-IBA-01 - European Reference Network on Rare hematological diseases – ERN-EuroBloodNet.",

year = "2023",

month = mar,

doi = "10.1097/HS9.0000000000000844",

language = "English",

volume = "7",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

Collado, A, Boaro, MP, Van Der Veen, S, Idrizovic, A, Biemond, BJ, Beneitez Pastor, D, Ortuño, A, Cela, E, Ruiz-Llobet, A, Bartolucci, P, De Montalembert, M, Castellani, G, Biondi, R, Manara, R, Sanavia, T, Fariselli, P, Kountouris, P, Kleanthous, M, Alvarez, F, Zazo, S, Colombatti, R, Van Beers, EJ & Mañú-Pereira, MDM 2023, 'Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet', HemaSphere, vol. 7, no. 3, e844. https://doi.org/10.1097/HS9.0000000000000844

TY - JOUR

T1 - Challenges and Opportunities of Precision Medicine in Sickle Cell Disease

T2 - Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

AU - Collado, Anna

AU - Boaro, Maria Paola

AU - Van Der Veen, Sigrid

AU - Idrizovic, Amira

AU - Biemond, Bart J.

AU - Beneitez Pastor, David

AU - Ortuño, Ana

AU - Cela, Elena

AU - Ruiz-Llobet, Anna

AU - Bartolucci, Pablo

AU - De Montalembert, Marianne

AU - Castellani, Gastone

AU - Biondi, Riccardo

AU - Manara, Renzo

AU - Sanavia, Tiziana

AU - Fariselli, Piero

AU - Kountouris, Petros

AU - Kleanthous, Marina

AU - Alvarez, Federico

AU - Zazo, Santiago

AU - Colombatti, Raffaella

AU - Van Beers, Eduard J.

AU - Mañú-Pereira, María Del Mar

N1 - Funding Information: GA 101017549 – GENOMED4ALL - H2020-SC1-FA-DTS-2020-1. ‘Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases’. Instituto de Salud Carlos III through the project ‘PI20/01454: ENABLING PERSONALIZED MEDICINE OF SICKLE CELL DISEASE PATIENTS BASED ON INTEGRATIVE DIAGNOSIS OF NEW GENERATION METHODOLOGIES’ (Co-funded by European Regional Development Fund/European Social Fund; ‘A way to make Europe’/’Investing in your future”). GA 101085717 - ERN-EuroBloodNet – EU4H-2022-ERN-IBA-01 - European Reference Network on Rare hematological diseases – ERN-EuroBloodNet.

PY - 2023/3

Y1 - 2023/3

UR - https://www.scopus.com/pages/publications/85149211000

U2 - 10.1097/HS9.0000000000000844

DO - 10.1097/HS9.0000000000000844

M3 - Comment/Letter to the editor

C2 - 36844183

AN - SCOPUS:85149211000

SN - 2572-9241

VL - 7

JO - HemaSphere

JF - HemaSphere

IS - 3

M1 - e844

ER -

Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet

Access to Document

Other files and links

Cite this